Annual EBIT
-$1.87 M
+$17.28 M+90.21%
December 1, 2023
Summary
- As of February 24, 2025, CYTO annual earnings before interest & taxes is -$1.87 million, with the most recent change of +$17.28 million (+90.21%) on December 1, 2023.
- During the last 3 years, CYTO annual EBIT has risen by +$7.38 million (+79.75%).
- CYTO annual EBIT is now at all-time high.
Performance
CYTO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
N/A
June 1, 2024
Summary
- CYTO quarterly earnings before interest & taxes is not available.
Performance
CYTO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
N/A
June 1, 2024
Summary
- CYTO TTM earnings before interest & taxes is not available.
Performance
CYTO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CYTO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +90.2% | - | - |
| 3 y3 years | +79.8% | - | - |
| 5 y5 years | +82.0% | - | - |
CYTO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +90.2% | ||||
| 5 y | 5-year | at high | +90.2% | ||||
| alltime | all time | at high | +93.8% |
Altamira Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$1.87 M(-90.2%) | - | - |
| Dec 2022 | -$19.15 M(+157.7%) | - | - |
| Dec 2021 | -$7.43 M(-19.7%) | - | - |
| Dec 2020 | -$9.26 M(+31.9%) | - | - |
| Dec 2019 | -$7.02 M(-32.7%) | - | - |
| Dec 2018 | -$10.43 M(-55.4%) | -$3.44 M(+17.9%) | -$10.42 M(-7.7%) |
| Sep 2018 | - | -$2.92 M(+12.9%) | -$11.29 M(-20.0%) |
| Jun 2018 | - | -$2.59 M(+75.5%) | -$14.12 M(-15.8%) |
| Mar 2018 | - | -$1.47 M(-65.8%) | -$16.77 M(-28.0%) |
| Dec 2017 | -$23.39 M(-20.5%) | -$4.31 M(-25.1%) | -$23.28 M(+2.5%) |
| Sep 2017 | - | -$5.75 M(+9.7%) | -$22.71 M(-8.1%) |
| Jun 2017 | - | -$5.24 M(-34.3%) | -$24.71 M(-12.0%) |
| Mar 2017 | - | -$7.98 M(+113.9%) | -$28.07 M(-4.2%) |
| Dec 2016 | -$29.41 M | -$3.73 M(-51.8%) | -$29.30 M(-4.5%) |
| Sep 2016 | - | -$7.75 M(-9.9%) | -$30.69 M(+8.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2016 | - | -$8.60 M(-6.7%) | -$28.30 M(-10.2%) |
| Mar 2016 | - | -$9.22 M(+80.2%) | -$31.52 M(+2.9%) |
| Dec 2015 | -$30.04 M(+63.9%) | -$5.11 M(-4.6%) | -$30.62 M(+5.8%) |
| Sep 2015 | - | -$5.36 M(-54.7%) | -$28.96 M(+6.7%) |
| Jun 2015 | - | -$11.83 M(+42.2%) | -$27.13 M(+29.9%) |
| Mar 2015 | - | -$8.32 M(+141.3%) | -$20.88 M(+8.9%) |
| Dec 2014 | -$18.33 M(+11.1%) | -$3.45 M(-2.4%) | -$19.17 M(-2.7%) |
| Sep 2014 | - | -$3.53 M(-36.7%) | -$19.70 M(-7.1%) |
| Jun 2014 | - | -$5.58 M(-15.5%) | -$21.22 M(+2.1%) |
| Mar 2014 | - | -$6.61 M(+65.9%) | -$20.77 M(+25.9%) |
| Dec 2013 | -$16.50 M(+227.3%) | -$3.98 M(-21.1%) | -$16.50 M(+31.8%) |
| Sep 2013 | - | -$5.05 M(-1.8%) | -$12.52 M(+67.5%) |
| Jun 2013 | - | -$5.14 M(+120.0%) | -$7.47 M(+220.0%) |
| Mar 2013 | - | -$2.34 M | -$2.34 M |
| Dec 2012 | -$5.04 M | - | - |
FAQ
- What is Altamira Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Altamira Therapeutics?
- What is Altamira Therapeutics annual EBIT year-on-year change?
- What is the all time high quarterly EBIT for Altamira Therapeutics?
- What is the all time high TTM EBIT for Altamira Therapeutics?
What is Altamira Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CYTO is -$1.87 M
What is the all time high annual EBIT for Altamira Therapeutics?
Altamira Therapeutics all-time high annual earnings before interest & taxes is -$1.87 M
What is Altamira Therapeutics annual EBIT year-on-year change?
Over the past year, CYTO annual earnings before interest & taxes has changed by +$17.28 M (+90.21%)
What is the all time high quarterly EBIT for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly earnings before interest & taxes is -$1.47 M
What is the all time high TTM EBIT for Altamira Therapeutics?
Altamira Therapeutics all-time high TTM earnings before interest & taxes is -$2.34 M